Assessing the Diagnostic Properties of a Graded Oral Provocation Challenge for the Diagnosis of Immediate and Nonimmediate Reactions to Amoxicillin in Children
Mill, Christopher, Primeau, Marie-Noël, Medoff, Elaine, Lejtenyi, Christine, O'Keefe, Andrew, Netchiporouk, Elena, Dery, Alizee, Ben-Shoshan, Moshe
Published in JAMA pediatrics (06.06.2016)
Published in JAMA pediatrics (06.06.2016)
Get more information
Journal Article
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1
Mill, Christopher P., Fiskus, Warren, DiNardo, Courtney D., Qian, Yimin, Raina, Kanak, Rajapakshe, Kimal, Perera, Dimuthu, Coarfa, Cristian, Kadia, Tapan M., Khoury, Joseph D., Saenz, Dyana T., Saenz, David N., Illendula, Anuradha, Takahashi, Koichi, Kornblau, Steven M., Green, Michael R., Futreal, Andrew P., Bushweller, John H., Crews, Craig M., Bhalla, Kapil N.
Published in Blood (04.07.2019)
Published in Blood (04.07.2019)
Get full text
Journal Article
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2
Mill, Christopher P., Fiskus, Warren, DiNardo, Courtney D., Birdwell, Christine, Davis, John A., Kadia, Tapan M., Takahashi, Koichi, Short, Nicholas, Daver, Naval, Ohanian, Maro, Borthakur, Gautam, Kornblau, Steven M., Green, Michael R., Qi, Yuan, Su, Xiaoping, Khoury, Joseph D., Bhalla, Kapil N.
Published in Blood (10.02.2022)
Published in Blood (10.02.2022)
Get full text
Journal Article
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
Fiskus, Warren, Daver, Naval, Boettcher, Steffen, Mill, Christopher P., Sasaki, Koji, Birdwell, Christine E., Davis, John A., Das, Kaberi, Takahashi, Koichi, Kadia, Tapan M., DiNardo, Courtney D., Burrows, Francis, Loghavi, Sanam, Khoury, Joseph D., Ebert, Benjamin L., Bhalla, Kapil N.
Published in Leukemia (01.11.2022)
Published in Leukemia (01.11.2022)
Get full text
Journal Article
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
Fiskus, Warren, Boettcher, Steffen, Daver, Naval, Mill, Christopher P., Sasaki, Koji, Birdwell, Christine E., Davis, John A., Takahashi, Koichi, Kadia, Tapan M., DiNardo, Courtney D., Jin, Qi, Qi, Yuan, Su, Xiaoping, McGeehan, Gerard M., Khoury, Joseph D., Ebert, Benjamin L., Bhalla, Kapil N.
Published in Blood cancer journal (New York) (11.01.2022)
Published in Blood cancer journal (New York) (11.01.2022)
Get full text
Journal Article
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
Lucas, Lauren M, Dwivedi, Vipasha, Senfeld, Jared I, Cullum, Richard L, Mill, Christopher P, Piazza, J Tyler, Bryant, Ianthe N, Cook, Laura J, Miller, S Tyler, Lott, 4th, James H, Kelley, Connor M, Knerr, Elizabeth L, Markham, Jessica A, Kaufmann, David P, Jacobi, Megan A, Shen, Jianzhong, Riese, 2nd, David J
Published in Pharmacological reviews (01.01.2022)
Published in Pharmacological reviews (01.01.2022)
Get full text
Journal Article
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
Birdwell, Christine E., Fiskus, Warren, Kadia, Tapan M., Mill, Christopher P., Sasaki, Koji, Daver, Naval, DiNardo, Courtney D., Pemmaraju, Naveen, Borthakur, Gautam, Davis, John A., Das, Kaberi, Sharma, Sunil, Horrigan, Stephen, Ruan, Xinjia, Su, Xiaoping, Khoury, Joseph D., Kantarjian, Hagop, Bhalla, Kapil N.
Published in Leukemia (01.03.2024)
Published in Leukemia (01.03.2024)
Get full text
Journal Article
SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents
Fiskus, Warren, Coothankandaswamy, Veena, Chen, Jianguang, Ma, Hongwei, Ha, Kyungsoo, Saenz, Dyana T, Krieger, Stephanie S, Mill, Christopher P, Sun, Baohua, Huang, Peng, Mumm, Jeffrey S, Melnick, Ari M, Bhalla, Kapil N
Published in Cancer research (Chicago, Ill.) (15.09.2016)
Published in Cancer research (Chicago, Ill.) (15.09.2016)
Get full text
Journal Article
Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCAD
Escudero, Silvia, Zaganjor, Elma, Lee, Susan, Mill, Christopher P., Morgan, Ann M., Crawford, Emily B., Chen, Jiahao, Wales, Thomas E., Mourtada, Rida, Luccarelli, James, Bird, Gregory H., Steidl, Ulrich, Engen, John R., Haigis, Marcia C., Opferman, Joseph T., Walensky, Loren D.
Published in Molecular cell (01.03.2018)
Published in Molecular cell (01.03.2018)
Get full text
Journal Article
Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015–2016
Smolina, Kate, Crabtree, Alexis, Chong, Mei, Zhao, Bin, Park, Mina, Mill, Christopher, Schütz, Christian G.
Published in Drug and alcohol dependence (01.01.2019)
Published in Drug and alcohol dependence (01.01.2019)
Get full text
Journal Article
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor
Fiskus, Warren, Piel, Jessica, Collins, Mike, Hentemann, Murphy, Cuglievan, Branko, Mill, Christopher P., Birdwell, Christine E., Das, Kaberi, Davis, John A., Hou, Hanxi, Jain, Antrix, Malovannaya, Anna, Kadia, Tapan M., Daver, Naval, Sasaki, Koji, Takahashi, Koichi, Hammond, Danielle, Reville, Patrick K., Wang, Jian, Loghavi, Sanam, Sen, Rwik, Ruan, Xinjia, Su, Xiaoping, Flores, Lauren B., DiNardo, Courtney D., Bhalla, Kapil N.
Published in Blood (16.05.2024)
Published in Blood (16.05.2024)
Get full text
Journal Article
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
Mill, Christopher P., Fiskus, Warren, Das, Kaberi, Davis, John A., Birdwell, Christine E., Kadia, Tapan M., DiNardo, Courtney D., Daver, Naval, Takahashi, Koichi, Sasaki, Koji, McGeehan, Gerard M., Ruan, Xinjia, Su, Xiaoping, Loghavi, Sanam, Kantarjian, Hagop, Bhalla, Kapil N.
Published in Leukemia (01.06.2023)
Published in Leukemia (01.06.2023)
Get full text
Journal Article
BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells
Saenz, D T, Fiskus, W, Manshouri, T, Rajapakshe, K, Krieger, S, Sun, B, Mill, C P, DiNardo, C, Pemmaraju, N, Kadia, T, Parmar, S, Sharma, S, Coarfa, C, Qiu, P, Verstovsek, S, Bhalla, K N
Published in Leukemia (01.03.2017)
Published in Leukemia (01.03.2017)
Get full text
Journal Article
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma
Fiskus, Warren, Mill, Christopher P., Perera, Dimuthu, Birdwell, Christine, Deng, Qing, Yang, Haopeng, Lara, Bernardo H., Jain, Nitin, Burger, Jan, Ferrajoli, Alessandra, Davis, John A., Saenz, Dyana T., Jin, Wendy, Coarfa, Cristian, Crews, Craig M., Green, Michael R., Khoury, Joseph D., Bhalla, Kapil N.
Published in Leukemia (01.09.2021)
Published in Leukemia (01.09.2021)
Get full text
Journal Article
Mechanistic basis and efficacy of targeting the β-catenin–TCF7L2–JMJD6–c-Myc axis to overcome resistance to BET inhibitors
Saenz, Dyana T., Fiskus, Warren, Mill, Christopher P., Perera, Dimuthu, Manshouri, Taghi, Lara, Bernardo H., Karkhanis, Vrajesh, Sharma, Sunil, Horrigan, Stephen K., Bose, Prithviraj, Kadia, Tapan M., Masarova, Lucia, DiNardo, Courtney D., Borthakur, Gautam, Khoury, Joseph D., Takahashi, Koichi, Bhaskara, Srividya, Lin, Charles Y., Green, Michael R., Coarfa, Cristian, Crews, Craig M., Verstovsek, Srdan, Bhalla, Kapil N.
Published in Blood (09.04.2020)
Published in Blood (09.04.2020)
Get full text
Journal Article
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML
Saenz, Dyana T., Fiskus, Warren, Manshouri, Taghi, Mill, Christopher P., Qian, Yimin, Raina, Kanak, Rajapakshe, Kimal, Coarfa, Cristian, Soldi, Raffaella, Bose, Prithviraj, Borthakur, Gautam, Kadia, Tapan M., Khoury, Joseph D., Masarova, Lucia, Nowak, Agnieszka J., Sun, Baohua, Saenz, David N., Kornblau, Steven M., Horrigan, Steve, Sharma, Sunil, Qiu, Peng, Crews, Craig M., Verstovsek, Srdan, Bhalla, Kapil N.
Published in Leukemia (01.06.2019)
Published in Leukemia (01.06.2019)
Get full text
Journal Article
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Fiskus, Warren, Mill, Christopher P., Birdwell, Christine, Davis, John A., Das, Kaberi, Boettcher, Steffen, Kadia, Tapan M., DiNardo, Courtney D., Takahashi, Koichi, Loghavi, Sanam, Soth, Michael J., Heffernan, Tim, McGeehan, Gerard M., Ruan, Xinjia, Su, Xiaoping, Vakoc, Christopher R., Daver, Naval, Bhalla, Kapil N.
Published in Blood cancer journal (New York) (13.04.2023)
Published in Blood cancer journal (New York) (13.04.2023)
Get full text
Journal Article
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)
Mill, Christopher P., Fiskus, Warren C., DiNardo, Courtney D., Reville, Patrick, Davis, John A., Birdwell, Christine E., Das, Kaberi, Hou, Hanxi, Takahashi, Koichi, Flores, Lauren, Ruan, Xinjia, Su, Xiaoping, Loghavi, Sanam, Khoury, Joseph D., Bhalla, Kapil N.
Published in Blood cancer journal (New York) (05.02.2024)
Published in Blood cancer journal (New York) (05.02.2024)
Get full text
Journal Article
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics
Cullum, Richard L, Lucas, Lauren M, Senfeld, Jared I, Piazza, John T, Neel, Logan T, Whig, Kanupriya, Zhai, Ling, Harris, Mackenzie H, Rael, Cristina C, Taylor, Darby C, Cook, Laura J, Kaufmann, David P, Mill, Christopher P, Jacobi, Megan A, Smith, Forrest T, Suto, Mark, Bostwick, Robert, Gupta, Ram B, David, Allan E, Riese Ii, David J
Published in PloS one (30.12.2020)
Published in PloS one (30.12.2020)
Get full text
Journal Article